Correlation Between Shuttle Pharmaceuticals and BioAffinity Technologies
Can any of the company-specific risk be diversified away by investing in both Shuttle Pharmaceuticals and BioAffinity Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shuttle Pharmaceuticals and BioAffinity Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shuttle Pharmaceuticals and bioAffinity Technologies Warrant, you can compare the effects of market volatilities on Shuttle Pharmaceuticals and BioAffinity Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shuttle Pharmaceuticals with a short position of BioAffinity Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shuttle Pharmaceuticals and BioAffinity Technologies.
Diversification Opportunities for Shuttle Pharmaceuticals and BioAffinity Technologies
0.84 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Shuttle and BioAffinity is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Shuttle Pharmaceuticals and bioAffinity Technologies Warra in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioAffinity Technologies and Shuttle Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shuttle Pharmaceuticals are associated (or correlated) with BioAffinity Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioAffinity Technologies has no effect on the direction of Shuttle Pharmaceuticals i.e., Shuttle Pharmaceuticals and BioAffinity Technologies go up and down completely randomly.
Pair Corralation between Shuttle Pharmaceuticals and BioAffinity Technologies
Given the investment horizon of 90 days Shuttle Pharmaceuticals is expected to under-perform the BioAffinity Technologies. But the stock apears to be less risky and, when comparing its historical volatility, Shuttle Pharmaceuticals is 2.2 times less risky than BioAffinity Technologies. The stock trades about -0.07 of its potential returns per unit of risk. The bioAffinity Technologies Warrant is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 17.00 in bioAffinity Technologies Warrant on April 30, 2025 and sell it today you would earn a total of 1.00 from holding bioAffinity Technologies Warrant or generate 5.88% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 54.1% |
Values | Daily Returns |
Shuttle Pharmaceuticals vs. bioAffinity Technologies Warra
Performance |
Timeline |
Shuttle Pharmaceuticals |
BioAffinity Technologies |
Risk-Adjusted Performance
OK
Weak | Strong |
Shuttle Pharmaceuticals and BioAffinity Technologies Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Shuttle Pharmaceuticals and BioAffinity Technologies
The main advantage of trading using opposite Shuttle Pharmaceuticals and BioAffinity Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shuttle Pharmaceuticals position performs unexpectedly, BioAffinity Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioAffinity Technologies will offset losses from the drop in BioAffinity Technologies' long position.Shuttle Pharmaceuticals vs. Lifecore Biomedical | Shuttle Pharmaceuticals vs. bioAffinity Technologies, | Shuttle Pharmaceuticals vs. Addentax Group Corp | Shuttle Pharmaceuticals vs. Virax Biolabs Group |
BioAffinity Technologies vs. bioAffinity Technologies, | BioAffinity Technologies vs. Exagen Inc | BioAffinity Technologies vs. Applied DNA Sciences | BioAffinity Technologies vs. AAP Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |